Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups.
Dubbelman MA, Hendriksen HMA, Harrison JE, Vijverberg EGB, Prins ND, Kroeze LA, Ottenhoff L, Van Leeuwenstijn MMSSA, Verberk IMW, Teunissen CE, van de Giessen EM, Van Harten AC, Van Der Flier WM, Sikkes SAM. Dubbelman MA, et al. Among authors: van de giessen em. Neurology. 2024 Jan 23;102(2):e207978. doi: 10.1212/WNL.0000000000207978. Epub 2023 Dec 26. Neurology. 2024. PMID: 38165338 Free PMC article.
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.
Koenders L, Machielsen MW, van der Meer FJ, van Gasselt AC, Meijer CJ, van den Brink W, Koeter MW, Caan MW, Cousijn J, den Braber A, van 't Ent D, Rive MM, Schene AH, van de Giessen E, Huyser C, de Kwaasteniet BP, Veltman DJ, de Haan L. Koenders L, et al. J Psychiatry Neurosci. 2015 May;40(3):197-206. doi: 10.1503/jpn.140081. J Psychiatry Neurosci. 2015. PMID: 25510948 Free PMC article.
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Chételat G, et al. Lancet Neurol. 2020 Nov;19(11):951-962. doi: 10.1016/S1474-4422(20)30314-8. Lancet Neurol. 2020. PMID: 33098804 Review.
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study.
Visser D, Verfaillie SCJ, Bosch I, Brouwer I, Tuncel H, Coomans EM, Rikken RM, Mastenbroek SE, Golla SSV, Barkhof F, van de Giessen E, van Berckel BNM, van der Flier WM, Ossenkoppele R. Visser D, et al. Among authors: van berckel bnm, van der flier wm, van de giessen e. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2409-2419. doi: 10.1007/s00259-023-06196-2. Epub 2023 Mar 28. Eur J Nucl Med Mol Imaging. 2023. PMID: 36976303 Free PMC article.
Finding our way through the labyrinth of dementia biomarkers.
Chételat G, Arbizu J, Barthel H, Garibotto V, Lammertsma AA, Law I, Morbelli S, van de Giessen E, Drzezga A. Chételat G, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2320-2324. doi: 10.1007/s00259-021-05301-7. Eur J Nucl Med Mol Imaging. 2021. PMID: 33876260 No abstract available.
The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee. Garibotto V, et al. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y. Eur J Nucl Med Mol Imaging. 2021. PMID: 34272989 No abstract available.
45 results